대한의생명과학회지 (Biomedical Science Letters)

  • 제20권4호
  • /
  • Pages.244-249
  • /
  • 2014
  • /
  • 1738-3226(pISSN)
  • /
  • 2288-7415(eISSN)
대한의생명과학회 (The Korean Society for Biomedical Laboratory Sciences)
권호 표지
DOI QR코드

DOI QR Code

Suppressive Effect of Arazyme on Neutrophil Apoptosis in Normal and Allergic Subjects

  • Kim, In Sik (Department of Biomedical Laboratory Science, School of Medicine, Eulji University) ;
  • Lee, Ji-Sook (Department of Clinical Laboratory Science, Wonkwang Health Science University)
  • 투고 : 2014.12.04
  • 심사 : 2014.12.22
  • 발행 : 2014.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Arazyme is a metalloprotease secreted by Aranicola proteolyticus that was previously shown to suppress cytokine expression of keratinocytes and endothelial cells and inhibit histopathological features in an atopic dermatitis-like animal model. However, the regulatory effects of arazyme in other allergic diseases have yet to be elucidated. In this study, we investigated whether arazyme is effective against neutrophil apoptosis in allergic diseases such as allergic rhinitis and asthma. Arazyme inhibited neutrophil apoptosis of normal subjects in a dose-dependent manner. However, the antiapoptotic effect of arazyme was reversed by LY294002, an inhibitor of PI3K, AKTi, an inhibitor of Akt, PD98059, an inhibitor of MEK, and BAY-11-7085, an inhibitor of NF-${\kappa}B$. Arazyme induced activation of NF-${\kappa}B$ via PI3K/Akt/ERK pathway. The anti-apoptotic effect of arazyme is associated with inhibition of cleavage of caspase 3 and caspase 9. Arazyme inhibited constitutive apoptosis of neutrophil in a dose-dependent manner in allergic subjects, and its mechanism was shown to be associated with PI3K/Akt/ERK/NF-${\kappa}B$. The results presented here improve our understanding of neutrophil apoptosis regulation and will facilitate development of drugs for treatment of allergic diseases.

키워드

참고문헌

  1. Bersanetti PA, Park HY, Bae KS, Son KH, Shin DH, Hirata IY, Juliano MA, Carmona AK, Juliano L. Characterization of arazyme, an exocellular metalloprotease isolated from Serratia proteamaculans culture medium. Enzyme Microb Technol. 2005. 37: 574-581. https://doi.org/10.1016/j.enzmictec.2005.01.041
  2. Bieber T. Atopic dermatitis. 2008. N Engl J Med. 358: 1483-1494. https://doi.org/10.1056/NEJMra074081
  3. Cookson WO, Moffatt MF. The genetics of atopic dermatitis. Curr Opin Allergy Clin Immunol. 2002. 2: 383-387. https://doi.org/10.1097/00130832-200210000-00003
  4. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol. 2008. 8: 218-230. https://doi.org/10.1038/nri2262
  5. Kang BK, Kim MA, Park SH, Lee EJ, Kim JS, Kim EJ, Baek SY, Kim IS. The house dust mite allergen, Dermatophagoides pteronyssinus regulates the constitutive apoptosis and cytokine secretion of human eosinophils. Biomed Sci Lett. 2014. 20: 39-42.
  6. Kim EH, Lee JS, Lee NR, Baek SY, Kim EJ, Lee SJ, Kim IS. Regulation of constitutive neutrophil apoptosis due to house dust mite allergen in normal and allergic rhinitis subjects. PLoS One. 2014c. 9: e105814. https://doi.org/10.1371/journal.pone.0105814
  7. Kim IS, Kim MJ, Shin DH, Son KH, Park HY, Lee JS. Arazyme inhibits cytokine expression and upregulates skin barrier protein expression. Mol Med Rep. 2013. 8: 551-556. https://doi.org/10.3892/mmr.2013.1520
  8. Kim IS, Lee NR, Baek SY, Kim EJ, Kim JS, Jeong TS, Shin DH, Park HY, Lee JS. Inhibitory effect of arazyme on the development of atopic dermatitis-like lesions in BALB/c and Nc/Nga mice. 2014a. Mol Med Rep. (in press)
  9. Kim IS, Yang EJ, Shin DH, Son KH, Park HY, Lee JS. Effect of arazyme on the lipopolysaccharide-induced inflammatory response in human endothelial cells. Mol Med Rep. 2014b. 10: 1025-1029. https://doi.org/10.3892/mmr.2014.2231
  10. Kwak J, Lee K, Shin DH, Maeng JS, Park DS, Oh HW, Son KH, Bae KS, Park HY. Biochemical and genetic characterization of arazyme, an extracellular metalloprotease produced from Serratia proteamaculans HY-3. J Microbiol Biotechnol. 2007. 17: 761-768.
  11. Ledoux AC, Perkins ND. NF-${\kappa}B$ and the cell cycle. Biochem Soc Trans. 2014. 42: 76-81. https://doi.org/10.1042/BST20130156
  12. Lim MC, Taylor RM, Naclerio RM. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavages. Am J Resir Crit Care. 1995. 151: 136-144. https://doi.org/10.1164/ajrccm.151.1.7812543
  13. Luo HR, Loison F. Constitutive neutrophil apoptosis: mechanisms and regulation. Am J Hematol. 2008. 83: 288-295. https://doi.org/10.1002/ajh.21078
  14. Monteseirin J. Neutrophils and asthma. J Investig Allergol Clin Immunol. 2009. 19: 340-354.
  15. Park JK, Jeong DH, Park HY, Son KH, Shin DH, Do SH, Yang HJ, Yuan DW, Hong IH, Goo MJ, Lee HR, Ki MR, Ishigami A, Jeong KS. Hepatoprotective effect of arazyme on CCl4-induced acute hepatic injury in SMP30 knock-out mice. Toxicology. 2008. 246: 132-142. https://doi.org/10.1016/j.tox.2008.01.006
  16. Scheel-Toellner D, Wang KQ, Webb PR, Wong SH, Craddock R, Assi LK, Salmon M, Lord JM. Early events in spontaneous neutrophil apoptosis. Biochem Soc Trans. 2004. 32: 461-464. https://doi.org/10.1042/BST0320461
  17. Simon HU. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol Rev. 2003. 193: 101-110. https://doi.org/10.1034/j.1600-065X.2003.00038.x
  18. Yang EJ, Choi E, Ko J, Kim DH, Lee JS, Kim IS. Differential effect of CCL2 on constitutive neutrophil apoptosis between normal and asthmatic subjects. J Cell Physiol. 2012. 227: 2567-2577. https://doi.org/10.1002/jcp.22995
  19. Zhang H, Zeng X, He S. Evaluation on potential contributions of protease activated receptors related mediators in allergic inflammation. Mediators Inflamm. 2014. 2014: 829068.